email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1711 - 1725
of 3612 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
Next
Bayer Enters $658 Million Deal to Market Hua's Diabetes Drug in China
$5.00
Available
GNI Reports Positive Results from Trial of Liver Fibrosis Drug
$5.00
Available
JW Therapeutics Files for $300 Million Hong Kong IPO
$5.00
Available
Henlius Biotech Approved to Launch Herceptin Biosimilar in China
$5.00
Available
Ascletis Doses Patients in China Trial of PD-L1 for Hepatitis B
$5.00
Available
Shanghai Pharma Signs $165 Million Deal for ImmVira Oncolytic Virus Program
$5.00
Available
Shanghai Hanyu Completes $72 Million Round for Cardiovascular Devices
$5.00
Available
MicuRx Receives $7.8 Million for Phase I/II Trials of Novel Antimicrobial
$5.00
Available
Cellular Biomedicine Accepts $383 Million Management-led Privatization Offer
$5.00
Available
Vision Medicals Raises $29 Million to Support Genetic Testing for Infectious Diseases
$5.00
Available
Viva Biotech to Pay $368 Million to Acquire Controlling Stake in China CDMO
$5.00
Available
Suzhou Zanrong Completes $20 Million A+ Round for Cancer Drugs
$5.00
Available
Innovent Reports Positive Data from Phase III Trial of Tyvyt for NSCLC
$5.00
Available
NeuPharma Starts Phase II Trial of Novel Treatment for Glioblastoma Multiforme
$5.00
Available
ABM Therapeutics Completes $20 Million Round for Neural Cancer Drugs
$5.00
Available